The Verisense platform provides complete clinical trial sponsor support, requiring a five-minute setup to initiate data collection and participant follow up.
Included in the deal are an upgraded on-device dashboard and goal-based exercise modes; also there are new apps and clock faces.
Two key factors are contributing to this growth, including the growing popularity of smartwatches and greater wearables adoption in emerging markets.
The filing describes a device with an array of sensors that would be able to reduce or stabilize involuntary movement in an adjacent joint or entire limb.
ActiGraph monitors are the most widely used devices of their kind, with 1,500+ clients at pharmaceutical, academic, and scientific institutions.
New products from Fitbit, Garmin and Huawei helped propel the basic wearables category, and so did the growing demand in markets across Asia/Pacific.
Announced as one of key features of Apple Watch Series 4, the ECG functionality will be released by the end of the year as part of the next software update.
The fitness tracker comes with connected GPS, integrated heart rate reader, and a battery life of up to 20 days; it's now up for pre-order for $129.95.
When it comes to the fourth quarter, Fitbit expects revenues to be greater than $560 million, with device sales down and a higher average selling price.
Fitabase has worked with over 150 academic and clinical institutions worldwide on over 500 studies with one singular goal: better research, better results.